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ase control clinical trial
a  b  s  t  r  a  c  t
Aim:  Survival  rates  after  out-of-hospital-cardiac-arrest  (OHCA)  differ  widely  between  EMS  systems.  Since
hypertonic  saline  appears  to improve  long-term  outcome  after  OHCA,  some  local  EMS  systems  have
included  it  in  their  treatment  protocols  for  OHCA.  Our  ﬁrst  aim  was  to give  a quality  review  of  one  of
these  protocols.  Our  second  aim  was  to assess  whether  short-term  survival  improves  when  hypertonic
saline is  used  in resuscitation  after  OHCA.
Methods:  Matched  pairs  were  identiﬁed  for  the  independent  “return  of spontaneous  circulation  (ROSC)
after  cardiac  arrest”  (RACA)  score  variables  and  for use  of  ACD-CPR,  adrenaline,  and  amiodarone  from
the  German  Resuscitation  Registry  (GRR)  for January  2000  to  March  2011.  Patients  received  either
2  ml kg−1 hypertonic  saline  with  hydroxyethyl  starch  (7.2% NaCl  with  6%  hydroxyethyl  starch  200,000/0.5,
HyperHAES® [HHS])  infused  intravenously  within  10 min  during  CPR  according  to  local  treatment  pro-
tocols  or  standard  of care  CPR  (NON-HHS).  The  primary  endpoint  was admission  to  hospital  rate  (with
spontaneous  circulation);  secondary  endpoint  was  ROSC  rate  in  relation  to RACA  score.
Results:  322  matched  pairs  were  deﬁned  for  14  variables.  Predicted  ROSC-rate  using RACA-score  was
similar  in  HHS  (44.63%)  and  NON-HHS  (43.63%;  p =  0.440).  In contrast,  190 (59.0%)  HHS  patients  achieved
ROSC  compared  with  only  136  NON-HHS  patients  (42.2%;  2: p < 0.0001).  Short  term  survival  measured
as  rate  of  “admission  to hospital  with  spontaneous  circulation”  was  achieved  in  169  HHS patients  (52.5%)
versus  108  NON-HHS  patients  (33.5%)  (OR  2.19;  95%CI:  1.592–3.009;  2: p  <  0.0001).
Conclusion:  Locally  implemented  treatment  protocols  using  hypertonic  saline/HES  after OHCA  are  safe
and effective.  Also,  we  veriﬁed  that  short-term  survival  rates  were  better  in  patients  receiving  HHS.©  2014  The  A
Abbreviations: ACD-CPR, active-compression–decompression cardiopulmonary resus
rillator; CA, cardiac arrest; CPC, cerebral performance category; CPR, cardiopulmonary 
ypertonic saline with hydroxyethyl starch (7.2% NaCl with 6% hydroxyethyl starch 200,
ut-of-hospital cardiac arrest; OR, odds ratio; PCI, percutaneous coronary intervention; p
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. Introduction
Out-of-hospital-cardiac-arrest (OHCA) is a major problem in all
ndustrialized countries with an incidence of more than 100 vic-
ims per 100,000 inhabitants per year.1 The incidence of treated
HCA is about 50 per 100,000 inhabitants per year2 but differs
etween emergency medical services (EMS) systems. The num-
er of live patients admitted to hospital ranges from 5 to 30 per
00,000 inhabitants each year.1,3,4 These widely varying survival
ates after OHCA between EMS  systems1,3,4 could be improved
y implementing high quality basic life support,5,6 adrenaline,7,8
r amiodarone9,10 during resuscitation and use of therapeutic
ypothermia,11,12 percutaneous coronary intervention (PCI),13,14
nd standard operating procedures in the post-resuscitation
hase.15
High quality basic life support to reperfuse the heart is the
rst step for cardiopulmonary resuscitation (CPR) success. It has
o be emphasized, however, that myocardial blood ﬂow (MBF) is
imited even when thoracic compressions are optimized. Therefore
harmacological measures, which potentially will further increase
BF  during CPR, are needed. One of these measures is the use
f adrenaline. Two randomized clinical trials (RCTs) demonstrated
hat adrenaline alone8 or combined with other intravenous drugs7
igniﬁcantly increases short-term survival after OHCA. Experimen-
al studies have shown that adrenaline increases MBF  during CPR by
asoconstriction.16 But other pathophysiological changes limiting
eperfusion like endothelial cell swelling, perivascular oedema,
olling and sticking of leukocytes, and haemoconcentration17–21
re not addressed by adrenaline. Experimental studies demon-
trated that pharmacological therapy using 2 ml  kg−1 body weight
ypertonic saline (7.2%) (HS) reduces these changes in several
nimal shock models.22–24 Such studies have also shown that treat-
ent with HS after CA improves microcirculatory reperfusion of
he brain and heart22,25–28 and short-term survival,26–28 reduces
rotein-S100 and troponin release after CPR,29 and improves neu-
ological recovery after forebrain ischaemia.30
Based on these ﬁndings we undertook a randomized clinical trial
RCT) using 2 ml  kg−1 body weight HS/hydroxyethyl starch (HES) or
ES alone during CPR after OHCA.31,32 In 200 patients, we  failed to
emonstrate that administration of HS improves admission to hos-
ital or hospital discharge rate. But in contrast, more OHCA patients
ere discharged with good neurological recovery after pharma-
ological treatment with hypertonic saline/HES.32 Unfortunately,
he relatively small number of 100 patients receiving hypertonic
aline/HES limits the impact of this RCT.
EMS  systems in Germany employ specially trained emergency
hysicians for Advanced Life Support (ALS). Based on experimen-
al studies and our RCT,32 local treatment protocols for the use of
ypertonic saline in OHCA treatment were developed ﬁrst in the
MS  systems of Bonn and Göppingen. According to these protocols,
ypertonic saline with HES is given during CPR if the emergency
hysician prescribes this solution for an individual.
The ﬁrst aim of the present study was to provide a quality review
f the implemented local treatment protocol in Göppingen, which
ncludes hypertonic saline/HES during CPR. Our second impor-
ant aim was to assess whether short-term survival after OHCA is
mproved when hypertonic saline/HES is given. For this main objec-
ive we used a matched-pairs-analysis using data in the German
esuscitation Registry (GRR).33,34
. MethodsThis is a retrospective case–control study performed in accor-
ance with the Helsinki Declaration and was  approved by the
thics committee of the regional medical board of registration (Lan-
esärztekammer Baden-Württemberg 29.01.13). 85 (2014) 628–636 629
Data for this study were taken from the GRR, which was
developed by the “Deutsche Gesellschaft für Anästhesiologie und
Intensivmedizin”. This registry covers 17 million inhabitants with
more than 27,000 patients after OHCA and more than 550 patients
receiving hypertonic saline/HES as a result of local treatment pro-
tocols. This registry is constructed in accordance with the Utstein
style.33,35 Time of cardiac arrest (CA) – deﬁned as the cessation
of cardiac mechanical activity35 – is recorded in the database. If
the beginning of CA is not witnessed, presumed time of CA is
documented. If rescuers on the scene do not consider trauma, sub-
mersion, drug overdose, asphyxia or exsanguination as cause of CA,
a cardiac aetiology is adopted.
The matched-pair analysis was approved by the scientiﬁc advi-
sory board of the GRR (Ref no: GRR 01/2013). Subjects in the
HHS group received 2 ml  kg−1 estimated bodyweight of hypertonic
saline with hydroxyethyl starch (HHS) (7.2% NaCl with 6% hydrox-
yethyl starch 200,000/0.5, HyperHAES®, Fresenius KABI, 61346 Bad
Homburg, Germany). This solution was infused intravenously in a
10-min interval during CPR before ROSC occurred. In patients found
in VF/VT the solution was  given after the ﬁrst shocks failed and in
patients with asystole/EMD hypertonic saline/HES was given after
the ﬁrst dose of i.v. epinephrine. Cases were excluded from the
analysis if they met one or more of the following criteria:
• Age < 18 years
• Traumatic CA/exsanguination
• Incomplete dataset for matching criteria or outcome
Subjects in the NON-HHS group did not receive HHS. All patients
were treated according to the European Resuscitation Guidelines
2000 or 2005 because the sample period spanned implementation
times for both (January 2000 through March 2011). According to
the above deﬁned inclusion and exclusion criteria, 11,125 subjects
were identiﬁed in the GRR (Fig. 1).
3. Emergency medical services (EMS) system of Göppingen
and the locally implemented treatment protocol
A detailed description of the EMS  system of Göppingen was
given by Neukamm et al.36 The EMS  system covers both urban
and rural areas, serves 192,000 inhabitants, and has a service area
of 354 km2. The ﬁrst vehicle reached 77.9% of the patients within
8 min  after alert. The BLS-D crew members are trained to perform
thorax compressions using an “active compression decompres-
sion device” combined with an “impedance threshold device”.37,38
Adrenaline, atropine and amiodarone were given according to
the guidelines. HHS is infused intravenously in 10 min  during
CPR before ROSC if the emergency physician prescribes this solu-
tion for the individual. In patients found in VF/VT the solution
was given after the ﬁrst shocks failed and in patients with asys-
tole/EMD hypertonic saline/HES was  given after the ﬁrst dose of
i.v. epinephrine. The EMS  system of Göppingen implemented this
protocol in 2005 and has delivered CPR Data to the GRR  since June
2006.
3.1. ROSC after CA (RACA) score
The RACA-score was  developed to predict short-term survival
after OHCA.34 It was  deﬁned using a multivariate logistic regres-
sion model, with “ever ROSC” as the short-term outcome variable.
The probability of “ever ROSC” was calculated using the formula
1/(1 + e−x), where x is the sum of the following independent factors
that have a signiﬁcant positive or negative impact on the probability
of “ever ROSC”:
• Age ≥80 years (−0.2);
630 C. Hahn et al. / Resuscitation 85 (2014) 628–636
Fig. 1. Flowchart for extracting the 322 matched pairs out of 11,744 patients in the German Resuscitation Registry (within the study period from January 2000 to March
2011).  The 322 patients of the HHS-group received CPR according to the ERC-guidelines and an infusion of 2 ml  kg−1 body weight of hypertonic saline with hydroxyethyl









vasystole (−1.1) or pulseless electric activity (PEA; −0.8) as ﬁrst
rhythm;
bystander CPR (+0.2);
location of arrest at a medical institution (+0.5), doctor’s ofﬁce
(+1.2), public place (+0.3), or nursing home (−0.3);
male gender (−0.2);
presumed aetiology of hypoxia (+0.7), intoxication (+0.5), or
trauma (−0.6);
time to the arrival of professionals (−0.04 per min); and
witnessed by laypeople (+0.6) or by professionals (+0.5)..2. Statistical analysis
Matched pairs were built ﬁrst on the basis of the RACA-score
ariables (variables 1–11) and, second, on therapeutic measureshaving shown their impact on short term survival in RCTs (variables
12–14):
(1) Gender female (YES/NO)
(2)  Age > 80 years (YES/NO)
(3)  Cardiac origin (YES/NO)
(4)  Collapse witnessed (YES/NO)
(5)  Bystander CPR performed (YES/NO)
(6)  First ECG rhythm shockable (YES/NO)
(7)  Location of arrest “nursing home” (YES/NO)
(8)  Location of arrest “public/doctor’s ofﬁce” (YES/NO)
(9)  Time until arrival ≤5 mina (YES/NO)
(10) Time until arrival = 6–10 mina (YES/NO)
(11) Time until arrival ≥10 mina (YES/NO)
37,38(12) Active Compression Decompression-CPR performed (YES/NO)
(13) Administration of adrenaline7,8 (YES/NO)
(14) Administration of amiodarone10 (YES/NO)
a Time until arrival = time interval from collapse/dispatch alert until ﬁrst EMS
vehicle stopped at scene.

























































Fig. 2. The predicted RACA-ROSC rate (%) is represented by the horizontal lines;
achieved ROSC rate is shown by the diamonds (±conﬁdence interval). Patients of
statistical signiﬁcance (HHS-group = 500.35 ± 337.29 ml;  NON-
HHS-group = 331.30 ± 216.68 ml;  p = 0.061).
Fig. 3. (Top panel) ROSC rate (%) of HHS- and NON-HHS-group; n = 322 in each
group; patients of the HHS-group received an infusion of 2 ml kg−1 body weight of
hypertonic saline with hydroxyethyl starch in a 10-min interval during CPR. (ROSC-
rate: HHS-group: 59.0%; NON-HHS-group: 42.2%; OR 1.97; CI 95%: 1.439–2.693; 2:C. Hahn et al. / Resusc
Matched pairs were created and all data were computed using
xcel XP (Microsoft Corp., Redmond, WA,  USA) and SPSS version
8 (SPSS Inc., Chicago, IL, USA). If more than one matching partner
as found for an HHS patient, the control patient was randomly
hosen. After the matching procedure was ﬁnished, 322 matched
airs were identiﬁed. The primary endpoint of the matched pairs
nalysis was “admission to hospital with spontaneous circulation”,
econdary endpoints were “ROSC rate” and “ROSC rate in relation
o RACA-score”.34
All numerical data are expressed as means ± standard deviation.
ifferences between groups were analysed for signiﬁcance by the
2-test and Student’s t-test. Statistical signiﬁcance was  assumed
or p < 0.05 and the conﬁdence interval was set to 95%.
. Results
Our ﬁrst aim was to provide a quality review of the implemented
ocal treatment protocol in Göppingen EMS  system. This OHCA pro-
ocol combines the concepts of high quality CPR, adrenaline, and
HS during CPR. Using this approach it has achieved remarkably
igh survival rates in 704 patients between June 2006 and March
013. The CPR incidence reached 55.3 per 100,000 inhabitants per
ear. Adrenaline and HHS were given to 80.5% and 36.1% of the
atients, respectively. ACD-ITV CPR was performed in only 37.5%
ue to delivery difﬁculties of the ITV devices during that period.
or all 704 patients, the predicted ROSC rate was 39.4% using RACA-
core,34 but we achieved a signiﬁcantly higher ROSC rate of 48.8%
CI 44.3–53.3%); the hospital admittance rate with spontaneous cir-
ulation reached 47.3%. Of the 704 patients, 15.8% were discharged
rom hospital. The hospital discharge rate for OHCA patients with
PC 1 and CPC 2 was a remarkable 13.1%. In the subgroup of patients
ith VF/VT and cardiac aetiology we counted 153 patients. Of these
atients 72.1% were admitted to hospital with spontaneous circu-
ation, 35.1% could be discharged from hospital and 31.8% could be
ischarged with CPC 1 or 2.
For our second aim of assessing whether short-term survival
fter OHCA is improved when hypertonic saline/HES is given, our
nalysis included 644 patients, 322 matching pairs. There were not
ny statistical differences between the HHS-group and the NON-
HS-group within the 14 matching variables listed above (Table 1).
The median age of the patients was 67.81 ± 13.72 years in
he HHS-group and 66.63 ± 15.54 years in the NON-HHS-group
p = 0.304). In both groups 72% of patients were male and 28% were
emale. Cardiac origin of arrest was presumed in 78.6% of both
roups. Time until arrival on scene of the ﬁrst team was similar
ith 4.78 ± 5.08 min  in the HHS-group and 5.03 ± 5.19 min  in the
ON-HHS-group (p = 0.258). Collapse was witnessed in 60.6% of
oth groups. Location of arrest was “nursing home” in 3.4% and
public” or “doctor’s ofﬁce” in 10.2% in both groups. First rhythm
as shockable in 32.3% and bystander-CPR was performed in 30.1%
f both groups.
No statistical differences were found between the HHS- and
ON-HHS-groups in drug administration for drugs with known
mpact on short-term survival. Adrenaline was given to 95.3% of
he patients in both groups with a mean dosage of 8.74 ± 5.75 mg
n the HHS-group and 9.01 ± 6.50 mg  in the NON-HHS-group
p = 0.587). Amiodarone was given to 35.4% of the patients of
ach group. When it was administered, the dosage in the groups
as the comparable (HHS-group = 294.30 ± 91.39 mg;  NON-HHS-
roup = 298.25 ± 95.92; p = 0.751).
For drugs without impact on short term survival the fol-
owing results were found. Vasopressin was given to 15.2% of
he patients in the HHS-group and 3.4% in the NON-HHS-group
p < 0.001), but the mean dosage was comparable when given
HHS-group = 40.41 ± 9.57 I.E.; NON-HHS-group = 34.64 ± 12.67the HHS-group received an infusion of 2 ml kg−1 body weight of hypertonic saline
with hydroxyethyl starch in a 10-min interval during CPR.
I.E.; p = 0.094). Atropine was  given to 32.3% of the patients in
both groups with similar dosages (HHS-group = 2.62 ± 0.81 mg;
NON-HHS-group = 2.70 ± 1.53 mg; p = 0.612) (Table 2).
Only the HHS-group received hypertonic saline/HES. The mean
volume administered in the HHS-group was 215.11 ± 48.17 ml.
Colloids were administered in 5.3% and 7.1% of the patients
in the HHS- and NON-HHS-groups, respectively (p = 0.327). The
HHS-group received slightly higher volumes of colloids than
the NON-HHS-group although the difference did not reachp  < 0.0001). (Bottom panel) Admission to hospital with spontaneous circulation rate
(%) of HHS- and NON-HHS-group; n = 322 in each group. Patients of the HHS-group
received an infusion of 2 ml kg−1 body weight of hypertonic saline with hydrox-
yethyl starch in a 10-min interval during CPR (admission-rate: HHS-group: 52.5%;
NON-HHS-group: 33.5%; OR 2.19; CI 95% 1.592–3.009; 2: p < 0.0001).
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Table 1
Matching criteria.
Overall HHS-group NON-HHS-group p-Value
Sex male (%) 72 72 72 1
Age  >80 years (%) 17.7 17.7 17.7 1
Cardiac origin (%) 78.6 78.6 78.6 1
Collapse witnessed (%) 60.6 60.6 60.6 1
Bystander-CPR (%) 30.1 30.1 30.1 1
First  rhythm shockable (%) 32.3 32.3 32.3 1
ACD-CPR (%) 45.0 45.0 45.0 1
Location rest home of the elderly (%) 3.4 3.4 3.4 1
Location public/doctor’s ofﬁce (%) 10.2 10.2 10.2 1
Time interval from collapse ≤5 min  (%) 56.5 56.5 56.5 1
Time  interval from collapse 6–10 min  (%) 30.7 30.7 30.7 1
Time  interval from collapse ≥10 min  (%) 12.7 12.7 12.7 1
Treatment with adrenaline (%) 95.3 95.3 95.3 1
Treatment with amiodarone (%) 35.4 35.4 35.4 1
































s-Value calculated by 2-test. Patients of the HHS-group received an infusion of 2 
uring  CPR.
Crystalloids were administered in 83.9% and 80.4% of the
atients in the HHS- and NON-HHS-group, respectively (p = 0.258).
he HHS-group received slightly higher volumes of crystalloids
han the NON-HHS-group (HHS-group = 718.36 ± 619.69 ml;  NON-
HS-group = 603.11 ± 321.96 ml;  p = 0.007).
.1. CPR success rates
Predicted ROSC-rate calculated by RACA-score was not different
etween groups (HHS-group = 44.63%; NON-HHS-group = 43.63%,
 = 0.440). The achieved ROSC rate in the NON-HHS group was
ot different from predicted value (NON-HHS predicted = 43.63%;
chieved = 42.2%, 95%CI: 36.8–47.6%). In contrast, HHS treat-
ent signiﬁcantly increased the achieved ROSC rate (HHS
redicted = 44.63%; achieved = 59.0%, 95%CI: 53.6–64.4%) (Fig. 2).
In the HHS-group 190 patients achieved ROSC compared
ith only 136 patients in the NON-HHS group (achieved ROSC-
ate: HHS-group = 59.0%; NON-HHS-group = 42.2%; OR 1.97; 95%CI:
.439–2.693; 2: p < 0.0001) (Fig. 3, top panel).
In addition the “admission to hospital rate” was signiﬁcantly
igher in the HHS-group. Admission to hospital with sponta-
eous circulation was achieved in 169 HHS patients and only 108
ON-HHS patients (HHS-group = 52.5%; NON-HHS-group = 33.5%;
R 2.19; 95%CI: 1.592–3.009; 2: p < 0.0001) (Fig. 3, bottom panel).
For better understanding when and how hypertonic saline/HES
olution in CPR might work, we analysed all subgroups – deﬁned
y the matching criteria – of the 644 patients our case–control
tudy. These subgroups were drawn from the 322 pairs by exclud-
ng those pairs which did not ﬁt to the subgroup criterion. For
hese subgroups we calculate RACA-ROSC rate, and rate of patients
admitted to hospital with spontaneous circulation” (Table 3 and
ig. 4). In all of these subgroups predicted ROSC-rate by RACA-
core were comparable between patients receiving HHS or not,




Adrenaline (mg) 8.87 ± 6.13 
Vasopressin (U) 39.35 ± 10.33 
Atropine (mg) 2.66 ± 1.22 
Thrombolysis (mg) 3997.60 ± 4073.54 35
Sodium bicarbonate (ml) 99.25 ± 86.02 
Amiodarone (mg) 296.27 ± 93.50 2
Lidocaine (mg) 108.33 ± 28.87 1
HHS  (ml) 2
ean ± standard deviation; p-value calculated by t-tests. Patients of the HHS-group rece
tarch in a 10-min interval during CPR.1 body weight of hypertonic saline with hydroxyethyl starch in a 10-min interval
patients receiving HHS. In terms of “hospital admission rate with
spontaneous circulation”, these differences were signiﬁcant for the
following subgroups: gender female (YES, NO), age of patients > 80
years (YES, NO), cardiac origin (YES, NO), collapse witnessed (YES,
NO), bystander-CPR performed (YES, NO), ﬁrst ECG-rhythm shock-
able (YES, NO), time interval until arrival of ﬁrst EMS vehicle ≤ 5 min
and 6–10 min  (YES, NO), time interval until arrival of ﬁrst EMS
vehicle ≥ 10 min  (NO), ACD-CPR performed (NO), administration of
adrenaline (YES), administration of amiodarone (YES, NO).
In conclusion the effect of HHS could be detected over all 644
patients and in all subgroups. But HHS might not be as effec-
tive if time interval until arrival of ﬁrst EMS  vehicle was  too long
(≥11 min), location of arrest was  “nursing home”, administration
of adrenaline was  not necessary and if ACD-CPR was  performed.
5. Discussion
The present study demonstrated that the locally implemented
treatment protocol in Göppingen using i.a. hypertonic saline/HES
after OHCA is very effective, because achieved ROSC-rate is higher
than predicted and 92 out of 704 patients survived with good neu-
rological recovery. In Göppingen the rate of survivors with CPC1 + 2
reached 13.1% or 7.2 per 100,000 inhabitants per year. This sur-
vival rate is much more higher than recently reported from the
“Resuscitation Outcome Consortium”, USA39,40 (survival: 6–8%, no
incidence reported) and from Denmark (2010: 3.7 survivors per
100,000 inhabitants per year).41
Second, we  veriﬁed that short-term survival rates were higher
in patients listed in the GRR as receiving HHS. In fact, the matched-
pairs analysis in 644 patients demonstrated that the administration
of 2 ml  kg−1 body weight HHS during CPR signiﬁcantly increased
“hospital admittance rate with ROSC” from 33.5% to 52.5% although
predicted ROSC-rate was similar in both groups. These results
are consistent with previous experimental studies26,27 and, in
S-group NON-HHS-group p
8.74 ± 5.75 9.01 ± 6.50 0.587
40.41 ± 9.57 34.64 ± 12.67 0.094
2.62 ± 0.81 2.70 ± 1.53 0.612
38.13 ± 4047.73 4353.32 ± 4124.06 0.467
87.86 ± 42.08 113.25 ± 118.76 0.129
94.30 ± 91.39 298.25 ± 95.92 0.751
00.00 ± 0 114.29 ± 37.80 0.424
15.11 ± 48.17 Not used
















Rate of hospital admission with spontaneous circulation Predicted ROSC rate by RACA score
[n of admission/n of patients (%)] 2-Test of HHS
vs NON-HHS
[%] [%] t-Test of HHS
vs NON-HHS
Overall HHS-group NON-HHS-group p HHS  NON-HHS-group p
All pairs 277/644 (43.0%) 169/322 (52.5%) 108/322 (33.5%) <0.0001 44.63 46.63 0.440
Subgroups
(1.)  Gender female = YES 79/180 (43.9%) 49/90 (54.4%) 30/90 (33.3%) 0.004 48.25 45.90 0.326
Gender  female = NO 198/464 (42.7%) 120/232 (51.7%) 78/232 (33.6%) <0.0001 43.23 42.76 0.757
(2.)  Age of patients > 80 years = YES 39/114 (34.2%) 25/57 (43.9%) 14/57 (24.6%) 0.030 40.76 36.58 0.141
Age  of patients > 80 years = NO 238/530 (44.9%) 144/265 (54.3%) 94/265 (35.5%) <0.0001 45.46 45.13 0.827
(3.)  Cardiac origin = YES 218/506 (43.1%) 133/253 (52.6%) 85/253 (33.6%) <0.0001 45.39 43.96 0.346
Cardiac  origin = NO 59/138 (42.8%) 36/69 (52.2%) 23/69 (33.3%) 0.025 41.84 42.44 0.789
(4.)  Collapse wittnesed = YES 190/390 (48.7%) 112/195 (57.4%) 78/195 (40.0%) <0.001 50.82 49.45 0.383
Collapse  wittnesed = NO 87/254 (34.3%) 57/127 (44.9%) 30/127 (23.6%) <0.0001 35.13 34.70 0.796
(5.)  Bystander-CPR performed = YES 93/194 (47.9%) 54/97 (55.7%) 39/97 (40.2%) 0.031 52.41 50.99 0.562
Bystander-CPR performed = NO 184/450 (40.9%) 115/225 (51.1%) 69/225 (30.7%) <0.0001 41.28 40.47 0.564
(6.)  First ECG rhythm shockable = YES 122/208 (58.7%) 75/104 (72.1%) 47/104 (45.2%) <0.0001 62.08 60.43 0.187
First  ECG rhythm shockable = NO 155/436 (35.6%) 94/218 (43.1%) 61/218 (28.0%) <0.001 36.31 35.62 0.559
(7.)  Location of arrest “nursing home” = YES 10/22 (45.5%) 6/11 (54.5%) 4/11 (36.4%) 0.392 38.36 42.45 0.274
Location  of arrest “nursing home” = NO 267/622 (42.9%) 163/311 (52.4%) 104/311 (33.4%) <0.0001 44.85 44.03 0.532
(8.)  Location of arrest public/doctor’s ofﬁce = YES 33/66 (50%) 19/33 (57.6%) 14/33 (42.4%) 0.218 55.67 50.91 0.272
Location  of arrest public/doctor’s ofﬁce = NO 244/578 (42.2%) 150/289 (51.9%) 94/289 (32.5%) <0.0001 43.37 42.80 0.669
(9.)  Time interval until arrival of ﬁrst EMS vehicle
≤5 min  = YES
161/364 (44.2%) 96/182 (52.7%) 65/182 (35.7%) <0.001 45.61 45.10 0.763
Time  interval until arrival of ﬁrst EMS vehicle
≤5 min  = NO
116/280 (41.4%) 73/140 (52.1%) 43/140 (30.7%) <0.0001 43.36 41.74 0.406
(10.)  Time interval until arrival of ﬁrst EMS vehicle
6–10 min  = YES
82/198 (41.4%) 55/99 (55.6%) 27/99 (27.3%) <0.0001 45.51 44.12 0.534
Time  interval until arrival of ﬁrst EMS vehicle
6–10 min  = NO
195/446 (43.7%) 114/223 (51.1%) 81/223 (36.3%) 0.002 44.24 43.42 0.603
(11.)  Time interval until arrival of ﬁrst EMS
vehicle ≥ 11 min  = YES
34/82 (41.5%) 18/41 (43.9%) 16/41 (39.0%) 0.654 38.17 36.00 0.553
Time  interval until arrival of ﬁrst EMS
vehicle ≥ 11 min  = NO
243/562 (43.2%) 151/281 (53.7%) 92/281 (32.7%) <0.0001 45.57 44.75 0.544
(12.)  ACD-CPR performed = YES 136/290 (46.9%) 76/145 (52.4%) 60/145 (41.4%) 0.060 43.28 43.00 0.877
ACD-CPR performed = NO 141/354 (39.8%) 93/177 (52.5%) 48/177 (27.1%) <0.0001 45.74 44.16 0.375
(13.)  Administration of adrenaline = YES 257/614 (41.9%) 158/307 (51.5%) 99/307 (32.2%) <0.0001 44.00 43.35 0.619
Administration of adrenaline = NO 20/30 (66.7%) 11/15 (73.3%) 9/15 (60.0%) 0.439 57.68 49.55 0.223
(14.)  Administration of amiodarone = YES 124/228 (54.4%) 73/114 (64.0%) 51/114 (44.7%) 0.003 50.68 48.65 0.363
Administration of amiodarone = NO 153/416 (36.8%) 96/208 (46.2%) 57/208 (27.4%) <0.0001 41.32 40.89 0.774
Subgroup analysis. Subgroups were deﬁned by the used matching criteria, those pairs were excluded which did not ﬁt to the speciﬁed criterion. Absolute numbers of admissions and patients, percentage; p-value calculated by
2-test or t-test. Patients of the HHS-group received an infusion of 2 ml kg−1 body weight of hypertonic saline with hydroxyethyl starch in a 10-min interval during CPR.


































tig. 4. Subgroup analysis using forest plot for the endpoint “hospital admission wit
airs  were excluded which did not ﬁt to the speciﬁed criterion. Patients of the HHS-g
tarch  in a 10-min interval during CPR.
art, with our RCT,31,32 which demonstrated an improvement
n neurological outcome at discharge from hospital. In that RCT
dministration of HHS increased the number of patients with “good
erebral performance or only moderate cerebral disability at dis-
harge” from 5% to 13% (2: p < 0.05; OR 2.9, 95%CI: 1.004–8.5).32
While the current study did not address any mechanisms that
ight be involved in the improved short-term survival after HHS
reatment in OHCA patients, results from previous studies offer
ossible explanations. In experimental studies22,26–28,42 and in the
CT32 HHS application during CPR led to an increase of serum
odium concentration; this osmotic gradient was shown to reduce
ndothelial cell swelling and increase capillary diameter in shock
odels, caused by a ﬂuid shift from intracellular to intravascular
pace.24 Also, in several experimental studies of CA using different
echniques to assess organ blood ﬂow, the administration of hyper-
onic saline improved myocardial and cerebral blood ﬂow during
PR.22,25–28 In these studies it was demonstrated that improved
yocardial reperfusion increases short term survival.26–28 A ﬁnal
ossibility is that, the better neurological recovery with appli-
ation of hypertonic saline after CA and forebrain ischaemia30,32
ould be the result of a reduced no-reﬂow-phenomenon22,43 and
n increased reperfusion of the brain in the ﬁrst hours after
PR25,28,42 as was  indicated by a reduced protein-S100 release after
PR.29
The application of 2 ml  kg−1 body weight HHS increases serum
odium level for a short period.32 This leads to ﬂuid shift from
he endothelium and the perivascular cells to the intravascular
ompartment and improves microcirculatory blood ﬂow. However,
dministration of hypertonic saline/HES during CPR does not cause
 pronounced volume expansion and haemodilution32 so this could
ot be the key mechanism of improved short-term survival with
mall volume resuscitation during CPR.
The dosage of HHS that we used in the matched pairs study and
he RCT was 2 ml  kg−1 body weight infused in 10 min  during CPR.taneous circulation”. Subgroups were deﬁned by the used matching criteria, those
eceived an infusion of 2 ml kg−1 body weight of hypertonic saline with hydroxyethyl
A higher dosage of 4 ml  kg−1 body weight – that is recommended
for haemorrhagic shock – was  not more effective than 2 ml  kg−1
body weight after experimental CA.26 We  therefore recommend
2 ml  kg−1 body weight hypertonic saline/HES for treatment of
OHCA.
Emergency physicians in Germany are well trained i.a. in endo-
tracheal intubation and establishing i.v. access. In the current study,
hypertonic saline/HES was  administered early in the CPR algo-
rithm during chest compressions, a short time after establishing
an i.v. access. This was  also the situation in our earlier RCT per-
taining to the Bonn EMS  system; infusion of hypertonic saline/HES
was started 14.8 ± 6.9 min  after collapse and ALS-measures began
12.0 ± 6.6 min  after collapse.32
In the presented data adrenaline was given to 95.3% of both
the HHS and NON-HHS groups in a mean dosage of 8.87 mg.
Adrenaline administration has been shown to increase short-term
survival in previous RCTs. In the study by Olasveengen et al.7
“hospital admission rate” after OHCA signiﬁcantly increased from
20.6% to 31.8% (OR 1.8; 95%CI: 1.322–2.462) in patients receiv-
ing intravenously administered drugs, mainly adrenaline. Jacobs
et al.8 demonstrated that adrenaline administered during CPR sig-
niﬁcantly increases hospital admittance rate from 13.0% to 25.4%
(OR 2.3; 95%CI: 1.4–3.6). In the current matched pairs analysis we
reported that including the administration of HHS during CPR to
subjects already receiving adrenaline signiﬁcantly increased hos-
pital admittance rate from 33.5% to 52.5% (2: p < 0.0001; OR 2.19;
95%CI: 1.592–3.009). Looking at these data, one is tempted to
conclude that adrenaline and hypertonic saline/HES have an addi-
tive positive impact on short-term survival after OHCA. Further
studies need to be completed before such a conclusion can be
made, however. In addition, we must highlight that pharmaco-
logical treatment with adrenaline and – most likely – hypertonic
saline/HES is only effective when “basic life support” is performed
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Negative side effects of small volume resuscitation after CA of
ardiac origin were not observed and seem unlikely since we  saw
 higher admission rate in the current matched pairs study and
he higher survival rates with good neurological recovery after
ypertonic saline/HES in our previous RCT.32 In fact some clini-
al studies demonstrate that the infusion of even a large volume of
old saline solution (up to 30 ml  kg−1 body weight) for the induc-
ion of hypothermia after CPR is safe and feasible,45,46 suggesting
hat small volume resuscitation has a negligible effect. Neverthe-
ess, safety aspects of the administration of hypertonic saline/HES
fter CPR from OHCA should be closely followed.
.1. Limitations
First, this is a case–control study and not a randomized clinical
rial. We therefore cannot exclude that inﬂuencing factors which
re not documented in the GRR or we did not know will have inﬂu-
nced the results. But the method we used – a matched pairs study
ased on the RACA-score – will have minimize the risk of an impor-
ant selection bias. This argument is supported by our ﬁnding, that
he predicted ROSC rate – calculated by the RACA score – did not
iffer signiﬁcantly between the two groups (HHS-group = 44.63%;
ON-HHS-group = 43.63%, p = 0.440).
Second, the patients of both groups were matched using all
nﬂuencing factors that were quantiﬁed in the logistic regres-
ion analysis for the deﬁnition of the RACA-score. In addition, the
atients were matched for those therapeutic measures with sta-
istically signiﬁcant impact on short-term survival, i.e., ACD-CPR,
drenaline and amiodarone. However, in Germany the measure-
ent of CPR quality after OHCA is not routinely used. For that
eason, it is possible that patients receiving HHS get better CPR
han patients in the NON-HHS group. To avoid this inﬂuence we
atched our patients for the use of ACD-CPR, which was equally
istributed to both groups and therefore ACD-CPR cannot explain
he better survival rates in the HHS-group.
Third, due to our long review period, patients were resuscitated
ccording to two different guidelines (2000 and 2005). The num-
er of patients within the time periods was equally distributed in
oth groups and recent studies showed no difference in outcome
f patients were treated according to different guidelines.39,47 But
ue to the fact, that our sample period ended in March 2011 we  do
ot know the effect of hypertonic saline/HES infusion during CPR
hen the 2010 ERC guidelines were implemented.
Fourth, rate of vasopressin application and amount of crys-
alloid infusion differed between the HHS and NON-HHS group
igniﬁcantly. However, since neither vasopressin48,49 nor crystal-
oid infusion inﬂuence short-term survival, it is unlikely that this
ffected our results.
.2. Conclusions
In conclusion, our method of a “matched pairs analysis” of sub-
ects retrieved from the GRR controlled most of the obviously
nown predictors of outcome after CPR. For this reason ROSC-
ate predicted by the RACA-score did not differ between the HHS-
nd NON-HHS-group. Our study clearly demonstrated that patients
eceiving hypertonic saline/HES while being resuscitated achieved
igniﬁcantly higher “ROSC” and “hospital admission rates” com-
ared with those being resuscitated conventionally. To the best of
ur knowledge the administration of hypertonic saline/HES during
PR is an easy, feasible, and safe measure to improve short-term
urvival after CA of non-traumatic aetiology. It could be a new phar-
acological approach to improve microcirculatory reperfusion of
he heart and brain during CPR. Further clinical trials are recom-
ended to verify the effect of this measure on long-term survival 85 (2014) 628–636 635
with good neurological recovery as demonstrated in the RCT by
Breil et al. in 2012.32
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